DSGN $10.52 +3.04%

DSGN · Design Therapeutics, Inc.

Track DSGN — free

$10.52 +0.31 (+3.04%) Play latest call Q3 2025 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$653.81M

Shares

64.04M

Volume · Nov 9 70.68K Avg daily vol (3M) 581.33K

Earnings call · FY2021 Q3

Design Therapeutics, Inc. (DSGN) Q3 2021 Earnings Call

Concluded Nov 9, 2021

Nov 9, 2021

Period: FY2021 Q3
Runtime: —
Sources: 2 artifacts

Diluted EPS -$0.21

Net income -$11.32M

Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Nov 9, 2021 10-Q report Filed Nov 9, 2021

More DSGN earnings call transcripts

Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →